Status:

COMPLETED

Tumor and Development (TED)

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Tumor and Abnormalities of the Development

Eligibility:

All Genders

Up to 18 years

Brief Summary

The overall project goal is to build a database of childhood cancers associated with developmental anomalies; it aims at identifying new syndromes of genetic predisposition and at enabling the further...

Detailed Description

Most of the solid cancers arising in the childhood develop from embryonic tissues. The frequent association of paediatric cancers and abnormalities of the development underlines the link between oncog...

Eligibility Criteria

Inclusion

  • Inclusion Criteria :
  • \- Patient who developed before the age of 18 years a solid tumour or a malignant or borderline hemopathy.
  • AND
  • Presenting one or several abnormality (ies) of the development provided it is not related to the treatment and\\or to the disease among:
  • organ malformation, familial or not
  • neuro-sensory deficit, familial or not
  • delay of psychomotor acquisitions
  • epilepsy (not as a sequelae of the tumour)
  • disorder of growth and\\or weight and\\or of the cranial perimeter
  • congenital, sporadic and\\or familial endocrine or metabolic disease
  • dysmorphy
  • Informed consent of patient and parents to this study OR
  • tumour predisposition syndrome or developmental abnormality in a familial context, the molecular basis might have been already identified or not
  • Exclusion Criteria:
  • absence of malignancy in the index case
  • lack of developmental anomalies in the index case or in a related first degree
  • abnormal development recognized as acquired (traumatic, toxic, infectious, perinatal…)
  • age \> 18 years at diagnosis of the tumor
  • Lack of informed consent of the legal representatives
  • The familial aggregations of cancer without developmental disease are not included in this study.

Exclusion

    Key Trial Info

    Start Date :

    June 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2022

    Estimated Enrollment :

    998 Patients enrolled

    Trial Details

    Trial ID

    NCT01915797

    Start Date

    June 1 2013

    End Date

    December 1 2022

    Last Update

    February 6 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hôpital Necker Enfants Malades

    Paris, France, 75015